Have you or your loved ones reached or are about to reach menopause? Do you suffer from hot flashes, poor sleep, skin or vaginal dryness, loss of libido?
Have you been told by your practitioner that you are not a candidate for hormone replacement therapy because of an increased risk of breast cancer or blood clots?
This medical information is largely inaccurate and perhaps you could safely be treated with Hormone Replacement Therapy.
With long-term use of HRT, patients often find themselves aging healthier with a lowered risk of the following:
Your unique genetic profile influences how your body processes hormones, metabolizes medications and responds to hormone replacement therapy (HRT).
By analyzing specific genetic markers, our testing can help answer if hormone replacement therapy (HRT) is right for you.
With long-term use of hormone replacement therapy, patients often find themselves aging healthier with a lowered risk of the following:
Call 765-524-3277 to Get Started
Consider this quick and painless genetic test that specifically screens for the proven genetic predispositions for breast cancer, ovarian cancer, and the most common genetic blood clotting disorders. Let a negative Estrosafe test give you the confidence to proceed with hormone replacement therapy through your doctor.
At Estrosafe, we empower women with cutting-edge genetic insights to optimize their health and well-being.
Our genetic testing provides personalized information to help you make informed decisions about your hormonal health, disease risks, and wellness.
Every woman goes through menopause. Some women are lucky and have fewer symptoms than others, although research shows that 70-80% of women do suffer significant symptoms.
Genetics play a vital role and allows our team to make informed decisions about whether or not HRT is safe for you.
Hormone therapy (HT) remains the most effective treatment for vasomotor symptoms (VMS) and the genitourinary syndrome of menopause (GSM) and has been shown to prevent bone loss and fracture.
Bone loss accelerates substantially in late perimenopause and continues at a similar pace in the first postmenopausal years.
A similar study of bone mineral density changes during menopause reveals that bone loss accelerates substantially in the late perimenopause and continues at a similar pace in the first postmenopausal years. Additionally, the rate of postmenopausal bone mineral changes is related to body weight and not ethnicity.
Our genetic tests are streamlined
- with no hidden fees or contracts.
Your kit will be shipped directly to your home in a discreet packaging.
Your analysis will come with advice and recommendations.
Insight from our test can help you navigate this stage of life with confidence.
Your genetic test will give you the confidence to be treated with hormone therapy and improve your long-term wellness.
A Word From Lindsey R. Rolston, MD
“Women lose 35% of their bone 10 years after menopause specifically due to estrogen loss.
The ratio of hip fractures and knee and hip replacement surgery has escalated to 70:30 (Women to Men) since the women’s health initiative study in 2002 recommended against HRT.
OSTEOPENIA occurs then in all ladies not receiving HRT for 10 years or more. More women will die following hip fractures than from breast cancer annually.”
Your personalized Estrosafe report can can help you break the cycle.
Receive an easy-to-understand breakdown of your genetic results and find peace of mind.
Understanding Your Unique Hormonal Blueprint Menopause is a natural phase of life, but the experience is different for every woman. Symptoms, risks, and treatment responses
The Hidden Danger of Osteoporosis As women age, bone density naturally declines, increasing the risk of fractures. Hip fractures are especially concerning, as they can lead
Menopause is a significant transition in a woman’s life, bringing both challenges and opportunities for renewed focus on health. While some women experience only mild
Have you been told by your practitioner that you are not a candidate for hormone replacement therapy because of an increased risk of breast cancer or blood clots? This medical information is largely inaccurate and perhaps you could safely be treated with hormone replacement therapy.
Consider this quick painless genetic test that specifically screens for the proven genetic predisposition for breast cancer, ovarian cancer, and the most common genetic predisposed blood clotting disorders.
